Panacos Pharmaceuticals, Inc.
PANC · OTC
9/30/2008 | 6/30/2008 | 3/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 33.3% | -48.6% | 59.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -30,233.3% | -49,477.8% | -22,508.6% | -40,727.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -33,966.7% | -54,122.2% | -24,320% | -42,495.5% |
| EPS Diluted | -0.15 | -0.18 | -0.16 | -0.175 |
| % Growth | 16.7% | -12.5% | 8.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |